Insider · CIK 0001895174
Thierry Chauche
Files at SGMT (Sagimet Biosciences Inc.). First filing Feb 12, 2026, latest Feb 12, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SGMT: Sagimet Biosciences Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | SGMTsell Sagimet Biosciences Inc. | $7,033 1,312 shares | -8% | +197% from low-45% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | SGMT Sagimet Biosciences Inc. | AGrant or award Series A Common Stock | +44,000 | $0.00 | $0 | 59,688 | Feb 20, 2026 |
| Feb 19, 2026 | SGMT Sagimet Biosciences Inc. | AGrant or award Stock Option (Right to Buy)derivative | +88,000 | $0.00 | $0 | 88,000 | Feb 20, 2026 |
| Feb 10, 2026 | SGMT Sagimet Biosciences Inc. | SOpen-market sale Series A Common Stock | -1,312 | $5.36 | $7,033 | 15,688 | Feb 12, 2026 |
| Feb 6, 2025 | SGMT Sagimet Biosciences Inc. | AGrant or award Series A Common Stock | +17,000 | $0.00 | $0 | 17,000 | Feb 7, 2025 |
| Feb 6, 2025 | SGMT Sagimet Biosciences Inc. | AGrant or award Stock Option (Right to Buy)derivative | +69,000 | $0.00 | $0 | 69,000 | Feb 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.